Retour aux projets

13545.1 PFLS-LS

Human genetics-driven discovery of memory-modulating drugs

Résumé

Human genetics-driven discovery of memory-modulating drugs

Textes supplémentaires

Abstract

This project capitalizes on genome-wide human genetic information to identify and test memory-modulating|drugs: In a large genome-wide association study of cognitive functions, we were able to identify several, potentially memory-modulating compounds. Three top candidates will be tested in clinical trials. The identification of memory-modulating drugs is key for improving treatment of disorders with memory|dysfunctions, such as Alzheimer¿s disease, schizophrenia, and posttraumatic stress disorder (PTSD).

Participants

Andreas Muhs

Wirtschaftspartner

AC Immune SA Andreas Muhs Bâtiment B / EPFL Innovation Park 1015 Lausanne VD CH

Dominique de Quervain

Kontaktperson

dominique.dequervain@unibas.ch

Universität Basel Dominique de Quervain Birmannsgasse 8 4055 Basel BS CH

Détails du projet

Office de recherche
INNOSUISSE
Statut du projet
Abgeschlossen
Type de projet
Forschungsprojekt
Date de début
2012-02-29
Date de fin
2015-12-31
Coûts totaux approuvés
CHF 813156.00
Section
20 Förderbereich Life Sciences
Domaine politique NABS
Industrielle Produktivität und Technologie

Disciplines de recherche

  • T115 Medical technology 100.0%